The FDA’s Reckless Endangering of Women Continues — for Now

The Supreme Court missed its chance to review the approval of abortion-by-mail, but it did supply a win for the conscience rights of medical professionals.

Share this story

The FDA headquarters in White Oak, Md., August 29, 2020

Andrew Kelly/Reuters

Over the last few years, we’ve seen pro-abortion advocates ramp up their activism. One of the most aggressive recent pro-abortion efforts has been the FDA’s decision to approve the distribution of abortion drugs by mail — without any requirement that a woman ever see a doctor in person. The organization I lead — Alliance Defending Freedom — challenged that action on behalf of doctors who are caring for the women harmed by the FDA’s unlawful actions.

The U.S. Supreme Court just ruled in our case. Unfortunately, the Court said that the doctors we represent cannot challenge the FDA’s recklessness. We are disappointed that the court did not address the FDA’s unlawful removal of the requirement for in-person doctor visits.

KW

About the Author

Kristen Waggoner

Kristen Waggoner is CEO, president, and chief counsel of Alliance Defending Freedom.

Comments

Advertisement

Advertisement